Vivimed Labs Limited Schedules 6th Committee of Creditors Meeting on August 18, 2026
Vivimed Labs Limited will hold its 6th Committee of Creditors meeting on August 18, 2026. This is a pre-facto intimation regarding the ongoing corporate insolvency resolution process.
The meeting of the Committee of Creditors is a crucial step in the corporate insolvency resolution process, impacting the company's future course of action and potential restructuring. Therefore, it has a medium impact.
The announcement is a routine procedural update regarding a meeting of the Committee of Creditors as part of the ongoing corporate insolvency resolution process. It does not contain any new financial information or significant business developments.
Vivimed Labs Limited, currently undergoing a corporate insolvency resolution process under an NCLT order dated April 15, 2026, has announced the pre-facto intimation of its sixth meeting of the Committee of Creditors (CoC).
The meeting is scheduled to be held on Tuesday, August 18, 2026, via Audio-Visual Means, in accordance with Regulation 19 of the Insolvency and Bankruptcy Board of India (Insolvency Resolution Process for Corporate Persons) Regulations, 2016.
This announcement serves as a prior notification of the upcoming CoC meeting. The company also provided a list of previously conducted CoC meetings, including the first meeting on May 25, 2026, the third meeting on June 18, 2026, the fourth meeting on July 4, 2026, an adjourned fourth meeting on July 7, 2026, and the fifth meeting on July 20, 2026.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under corporate insolvency resolution process. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.